Effects of hypocretin (orexin) neuronal loss on sleep and extracellular adenosine levels in the rat basal forebrain.
Neurons containing the neuropeptide hypocretin (HCRT, orexin) are localized only in the lateral hypothalamus, from where they innervate multiple regions implicated in arousal, including the basal forebrain. HCRT activation of downstream arousal neurons is likely to stimulate release of endogenous factors. One such factor is adenosine, which in the basal forebrain increases in level with wakefulness and decreases with sleep, and is hypothesized to regulate the waxing and waning of sleep drive. Does loss of HCRT neurons affect adenosine levels in the basal forebrain? Is the increased sleep that accompanies HCRT loss a consequence of higher adenosine levels in the basal forebrain? In the present study, we investigated these questions by lesioning the HCRT neurons with HCRT-2-saporin (HCRT-2-SAP) and measuring sleep and extracellular levels of adenosine in the basal forebrain. In separate groups of rats, the neurotoxin HCRT-2-SAP or saline was administered locally to the lateral hypothalamus, and 80 days later adenosine and sleep were assessed. Rats given the neurotoxin had a 94% loss of HCRT neurons. These rats woke less at night, and had more rapid eye movement sleep, which is consistent with HCRT hypofunction. These rats also had more sleep after brief periods of sleep deprivation. However, in the lesioned rats, adenosine levels did not increase with 6 h of sleep deprivation, whereas an increase in adenosine levels occurred in rats without lesion of the HCRT neurons. These findings indicate that adenosine levels do not increase with wakefulness in rats with a HCRT lesion, and that the increased sleep in these rats occurs independently of adenosine levels in the basal forebrain.
Murillo-Rodriguez
Eric
E
Department of Neurology, Harvard Medical School, VA Medical Center, West Roxbury, MA 02132, USA.
Liu
Meng
M
Blanco-Centurion
Carlos
C
Shiromani
Priyattam J
PJ
D000241:Adenosine / Q000378:metabolism*; D000818:Animals; D047908:Intracellular Signaling Peptides and Proteins / Q000378:metabolism*; D008297:Male; D017551:Microdialysis; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D009479:Neuropeptides / Q000378:metabolism* / Q000494:pharmacology / Q000633:toxicity; D000068797:Orexins; D016548:Prosencephalon / Q000166:cytology / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D054789:Ribosome Inactivating Proteins, Type 1 / Q000494:pharmacology / Q000633:toxicity; D000076985:Saporins; D012890:Sleep / Q000502:physiology*; D012892:Sleep Deprivation / Q000378:metabolism; D014118:Toxins, Biological / Q000494:pharmacology / Q000633:toxicity; D014851:Wakefulness / Q000502:physiology
D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D000068797:Orexins; D054789:Ribosome Inactivating Proteins, Type 1; D014118:Toxins, Biological; C435665:hypocretin-2-saporin conjugate; D000076985:Saporins; D000241:Adenosine
Brain Res. 1996 Mar 11;712(1):53-9
8705307
Front Biosci. 2003 Sep 01;8:d1146-69
12957822
Neuroscience. 2001;106(4):699-715
11682157
Neuroscience. 2000;99(3):507-17
11029542
Neuron. 2005 Apr 21;46(2):297-308
15848807
J Neurosci Methods. 1980 Dec;3(2):129-49
6110810
Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):322-7
9419374
Electroencephalogr Clin Neurophysiol. 1994 Jan;90(1):24-35
7509271
Brain Res. 1999 May 8;827(1-2):243-60
10320718
Neuron. 2005 Jun 2;46(5):787-98
15924864
Cell. 1999 Aug 20;98(4):437-51
10481909
J Neurosci. 1986 Jul;6(7):1952-61
2426424
J Comp Neurol. 1997 Jun 30;383(2):163-77
9182846
J Neurosci. 2006 Aug 2;26(31):8092-100
16885223
Electroencephalogr Clin Neurophysiol. 1978 Nov;45(5):621-7
81764
Neuroscience. 1994 Jun;60(3):665-77
7936193
J Neurophysiol. 2000 Sep;84(3):1627-35
10980032
J Neurosci. 2004 Jul 14;24(28):6291-300
15254084
Arch Ital Biol. 2001 Apr;139(3):313-28
11330208
Sleep. 1991 Apr;14(2):116-20
1650958
J Neurosci. 2000 Feb 15;20(4):1505-18
10662840
Brain Res. 1992 Oct 23;594(1):150-4
1467935
Science. 1997 May 23;276(5316):1265-8
9157887
Am J Physiol Regul Integr Comp Physiol. 2000 Jan;278(1):R125-33
10644630
Eur J Neurosci. 2006 Oct;24(7):2084-8
17067305
J Neurosci. 2001 Sep 15;21(18):7273-83
11549737
Neurodegeneration. 1995 Mar;4(1):61-70
7600185
Neuroscience. 2007 Aug 10;148(1):34-43
17618058
J Comp Neurol. 1998 Dec 28;402(4):442-59
9862320
J Neurosci. 2004 May 5;24(18):4469-77
15128861
Front Biosci. 2003 May 01;8:s438-51
12700104
Neuroscience. 2003;116(1):223-35
12535955
J Neurosci. 2005 Jul 13;25(28):6716-20
16014733
Cell. 1998 Feb 20;92(4):573-85
9491897
J Neurosci. 1998 Dec 1;18(23):9996-10015
9822755
J Comp Neurol. 1988 Jan 15;267(3):433-53
2449477
Neuron. 2001 May;30(2):345-54
11394998
J Neurosci. 2008 Jan 9;28(2):491-504
18184792
Behav Brain Res. 2000 Nov;115(2):183-204
11000420
J Neurosci. 1988 Nov;8(11):4007-26
3183710
Neuroscience. 2001;108(2):177-81
11734353
Neuroscience. 2004;123(2):361-70
14698744